Results 1 to 10 of about 205,512 (182)

Co-expression and impact of prostate specific membrane antigen and prostate specific antigen in prostatic pathologies [PDF]

Journal of Experimental & Clinical Cancer Research, 2010
Background The present study was undertaken to relate the co-expression of prostate-associated antigens, PSMA and PSA, with the degree of vascularization in normal and pathologic (hyperplasia and cancer) prostate tissues to elucidate their possible role ...
Nouira Yassin, Ouertani Latifa, Rais Nawfel, Banasr Ahmed, Sallami Sataa, Bouraoui Yosra, Ben Jemaa Awatef, Horchani Ali, Oueslati Ridha   +8 more
doaj   +5 more sources

Prostate-Specific Membrane Antigen-Based Therapeutics [PDF]

Advances in Urology, 2012
Prostate cancer (PC) is the most common noncutaneous malignancy affecting men in the US, leading to significant morbidity and mortality. While significant therapeutic advances have been made, available systemic therapeutic options are lacking.
Naveed H. Akhtar, Orrin Pail, Ankeeta Saran, Lauren Tyrell, Scott T. Tagawa   +4 more
doaj   +6 more sources

Biomarkers in Prostate-Specific Membrane Antigen Theranostics [PDF]

Diagnostics, 2021
Theranostics of prostate cancer (PC) represents a growing area of development of imaging agents and targeted radionuclide therapeutics against a major target, prostate specific membrane antigen (PSMA).
Panagiotis J. Vlachostergios, Ioannis Zachos, Vassilios Tzortzis   +2 more
doaj   +3 more sources

Incidental prostate-specific membrane antigen-avid glioblastoma detected on 68Ga–prostate-specific membrane antigen PET/CT

Radiology Case Reports, 2022
A 74-year-old man was referred for a 68Ga–prostate-specific membrane antigen (PSMA) PET/CT scan for newly diagnosed prostate cancer which confirmed the presence of PSMA avid cancer in the right gland with no evidence of PSMA metastasis.
James Yuheng Jiang, MD, MMed, Christine Kang, MD, MMed, Paul Bui, MBBS, FRANZCR, FAANMS, Robert Mansberg, MBBS, FRACP, FAANMS   +3 more
doaj   +3 more sources

Incidental prostate-specific membrane antigen-avid meningioma detected on 68Ga–prostate-specific membrane antigen PET/CT

Radiology Case Reports, 2021
A 70-year-old gentleman with a history of Gleason score 7 (3 + 4) prostate adenocarcinoma was treated with radical prostatectomy with clear surgical margins. Postoperatively his prostate specific antigen was undetectable.
James Yuheng Jiang, MD, MMed (ClinEpi), Joshua Wei Liang Yip, MBBS, Christine Kang, MD, MMed (ClinEpi), Vu Hoang Tran, MD, Marco Enoch Lee, MD, Ken Le, MBBS, FRANZCR, Robert Mansberg, MBBS, FRACP, FAANMS   +6 more
doaj   +3 more sources

Prostate-Specific Membrane Antigen Expression in Patients with Primary Prostate Cancer: Diagnostic and Prognostic Value in Positron Emission Tomography-Prostate-Specific Membrane Antigen [PDF]

Current Oncology
Prostate cancer represents a significant public health challenge, with its management requiring precise diagnostic and prognostic tools. Prostate-specific membrane antigen (PSMA), a cell surface enzyme overexpressed in prostate cancer cells, has emerged ...
Omar Tayara, Sławomir Poletajew, Wojciech Malewski, Jolanta Kunikowska, Kacper Pełka, Piotr Kryst, Łukasz Nyk   +6 more
doaj   +2 more sources

Evaluation of Phage Display Discovered Peptides as Ligands for Prostate-Specific Membrane Antigen (PSMA) [PDF]

, 2013
The aim of this study was to identify potential ligands of PSMA suitable for further development as novel PSMA-targeted peptides using phage display technology. The human PSMA protein was immobilized as a target followed by incubation with a 15-mer phage
A Ghosh, AC Pawlyk, AM Quinn, CW Diehnelt, D Hessels, D Shen, DB Sodee, Duanwen Shen, E Basch, F Yi, Fei Xie, GA Lazar, H Liu, H Liu, H-S Lim, HD Agnew, IM Thompson, Irina U. Agoulnik, J Yu, JA Arter, JR Mesters, JR Newton, KA Noren, MI Davis, MI Milowsky, MJ Morris, MJ Morris, MJ Roobol, NH Bander, RK Nam, S Aggarwal, S Kim, S Minner, SE Lupold, SM Hillier, SR Banerjee, SR Banerjee, SR Banerjee, SR Banerjee, SS Chang, SZ Li, TJ Wigle, V Humblet, W. Barry Edwards, Y Chen, Y Chen, Y Chen, Z Xiao, ZY Zhu   +48 more
core   +23 more sources

A Review of Prostate Cancer and the Effect of Lutetium Radiopharmaceutical [PDF]

Translational Research in Urology, 2023
Introduction: Prostate cancer is a type of disease in which malignant cells originate from prostate tissue and multiply irregularly and increasingly, leading to an increase in volume in each of the cellular components of the prostate gland.  Methods: The
Akram Amani, Bentolhoda Rashidi
doaj   +1 more source

18F DCFPyL PSMA avid biopsy proven subcutaneous capillary haemangioma as a malignancy mimic in the setting of biochemical recurrent prostate carcinoma

Radiology Case Reports, 2022
We present a case of a 65-year-old male with a biopsy proven subcutaneous capillary haemangioma identified on imaging for evaluation of further metastatic spread of prostatic carcinoma due to a rise in his prostate-specific antigen biochemistry.
Manvinder Dhillon, MBBS, BMedSci, PGDAAD, MS, Dalveer Singh, MBBS, FRANZCR, FAANMS   +1 more
doaj   +1 more source

Prostate-Specific Membrane Antigen–Guided Surgery [PDF]

Journal of Nuclear Medicine, 2019
Since its introduction to the diagnostic pathway for prostate cancer management, prostate-specific membrane antigen (PSMA)-ligand PET has demonstrated great potential. PSMA-ligand imaging is increasingly influencing therapeutic decision making, although its impact on patient outcomes still needs to be defined.
Maurer, T., Graefen, M., Poel, H. van der, Hamdy, F., Briganti, A., Eiber, M., Wester, H.J., Leeuwen, F.W.B. van   +7 more
openaire   +4 more sources